Hello there.
Hundreds of investing and finance newsletters hit my (and maybe your) inbox every week. This is the best of the best of finance from last week. Friday, we’ll cover tech, and next Monday, we’ll tackle policy.
This week, we’ve got…
🥣 Wall Street’s Eating Good, but Is It Too Early?
🌱 Building a Future Beyond the Dollar
⚡️ Finance Quick Fix
🎭 Winners & Losers
😆 Meme of the Week
📈 Top Stock Ideas
With how quickly the market and investment climate are changing right now, we can’t afford to fall behind. You can always read the latest and most relevant finance news & updates at FinanceWrapped.com.
And for daily deep dives covering everything from stocks and crypto to trade relations, AI investment signals, and more, subscribe to our daily newsletter Stocks & Income.
In partnership with Pacaso
Keep This Stock Ticker on Your Watchlist
They’re a private company, but Pacaso just reserved the Nasdaq ticker “$PCSO.”
No surprise the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. What is unique is Pacaso is giving the same opportunity to everyday investors. And 10,000+ people have already joined them.
Created a former Zillow exec who sold his first venture for $120M, Pacaso brings co-ownership to the $1.3T vacation home industry.
They’ve generated $1B+ worth of luxury home transactions across 2,000+ owners. That’s good for more than $110M in gross profit since inception, including 41% YoY growth last year alone.
And you can join them today for just $2.90/share. But don’t wait too long. Invest in Pacaso before the opportunity ends September 18.
Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.
Please support our partners!
🥣 Wall Street’s Bowling for Soup
Stocks are riding high on the idea that 2.9% inflation is “just right” for the Fed to cut rates without killing consumer demand. That’s the Goldilocks dream, but strategists at Morgan Stanley and JPMorgan warn the rally could stall once the cut actually lands and investors start staring down a slowing economy. Rate cuts may spark a sugar high, but the hangover could come fast.
Me with a $274 crypto portfolio waiting for the FED rate cut decision
— #Trader Theory (#@Trader_Theory)
6:54 PM • Sep 16, 2025
Meanwhile, corporate America is doing its part to keep prices buoyant. JPMorgan sees buybacks jumping another $600 billion after a record $1.5 trillion this year, shrinking share supply and juicing EPS. Add in President Trump’s push to scrap quarterly reports in favor of semi-annual disclosures, and investors may soon have less frequent data to judge whether those buybacks are masking weakness or fueling real growth.
*SEC SAYS IT IS 'PRIORITIZING' TRUMP'S PROPOSAL TO END QUARTERLY EARNINGS REPORTS AFTER HIS REQUEST
Realize where we are.
— #Geiger Capital (#@Geiger_Capital)
1:01 AM • Sep 16, 2025
The market’s next leg depends on whether consumer spending holds up and whether companies can keep engineering EPS growth.
🌱 Betting on People, Not Just Profits
Blackstone’s Jon Gray says Ivy League diplomas aren’t the ticket to the top anymore. What matters is work ethic, entrepreneurial thinking, and even kindness: skills that AI can’t automate. With a weak labor market and one-third of grads calling their degree a waste of money, companies are shifting to skills-based hiring, and investors should be watching firms that adapt fastest.
I have a billionaire client who signed up with a “longevity doctor” for $120k a year
After a bunch of expensive tests she came up with this longevity protocol:
She’s putting him on TRT and Ozempic
Brilliant work
— #Shaun Tobin (#@ShaunTobikosan)
2:56 PM • Mar 15, 2025
At the same time, billionaires like Peter Thiel and Sam Altman are pouring more than $5 billion into longevity science, chasing the dream of living to 150. It’s partially a reasoned bet on biotech as the next trillion-dollar industry, with a pinch of supervillian origin story for good measure.
Here are the top 3 biotech stocks according to AltIndex’s AI model stock ratings:
In partnership with Surf Lakes
Grow globally with the most affordable Employer of Record
Hire top international talent without setting up legal entities in each country.
RemoFirst supports EOR and contractor payments in 185+ countries with no annual contracts and transparent pricing.
Whether you’re a startup or scaling enterprise, you’ll get hands-on support and built-in tools for international payroll, health benefits, taxes, and more.
Please support our partners!
⚡️ Finance Quick Fix
Robinhood unveiled a publicly traded venture capital fund, giving retail investors access to start‑ups once reserved for institutions.
Alphabet became the fourth company to hit a $3 trillion market cap, lifted by a favorable antitrust ruling that eased fears of a Chrome divestiture.
Chipotle’s stock came under pressure after the company warned of slowing traffic and higher labor costs.
Investor bullishness hit its highest level since February, according to the latest AAII sentiment survey.
🎭 Winners & Losers
A lot can happen in a week!
Let’s take a quick look at who struck gold and who struck out since our last issue:
🏆 Winners
Alphabet Inc. (GOOG): +7.70%
NVIDIA Corporation (NVDA): +4.01%
Microsoft Corporation (MSFT): +2.95%
Meta Platforms, Inc. (META): +1.91%
Apple Inc. (AAPL): +0.54%
😞 Losers
🫡 Meme of the Day
Meet the billionaire who spends $2 million per year to stay young
— #Neeraj K. Agrawal (#@NeerajKA)
3:44 PM • Sep 13, 2023
📈 Stock ideas
Analysis provided by altindex.com.
Remember to always DYOR.
Credo Technology $CRDO
Credo Technology designs and manufactures high-performance, cost-effective semiconductor solutions for a variety of markets, including telecommunications, networking, and data infrastructure. The company is recognized for its innovative technology, enabling increased data speeds and reduced power consumption.
The signals:
Revenue: $223M. That’s a 31.20% increase QoQ, up 273.57% YoY
Net income: $63M. Up 73.28% QoQ and up 764.56% YoY
Short- and long-term bullish price trend
10% increase in job postings
87% positive employee outlook
6% increase in Twitter following
Current price: $162.18
Target price: $195.04
Embraer $ERJ
Embraer S.A., a prominent Brazilian aerospace conglomerate, is renowned for its commercial, executive, and military aircraft. Founded in 1969, Embraer has established a global footprint with an extensive portfolio that extends beyond aircraft manufacturing to provide integrated solutions for its clients and partners.
The signals:
Revenue: $1.82B. Up 64.93% QoQ and 21.75% YoY
Net income: $79M. Increased 7.08% QoQ but decreased 20.93% YoY
Positive long-term price momentum
Negative short-term price momentum
10% increase in job postings
22% increase in web traffic
Current price: $56.29
Target price: $67.06
⭐️ What did you think of today's edition?
That’s all for today. Write us and let us know your thoughts on the market, the newsletter, or the weather—we’d just love to hear from you.
Till next time,
— Brandon and Blake of Invested Inc.
Disclosures
The information provided in Finance Wrapped is for informational and educational purposes only and should not be construed as financial advice, investment advice, or a recommendation to buy or sell any securities. Finance Wrapped is not a registered investment advisor, broker-dealer, or licensed financial planner. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We may hold positions in or receive compensation from the companies or products mentioned. Disclosures will be made where applicable.